Strive Health, a Denver, CO-based company which specializes in value-based kidney care, raised $166M in Series C funding.
The round was led by EA alongside CVS Health Ventures. Other investors included CapitalG (Alphabet), Echo Ventures, Town Hall Ventures, Ascension Ventures and Redpoint.
The company intends to use the funds to grow and scale the business by expanding into new markets, investing in its existing payor, health system, nephrologist and medical group partnerships and refining its clinical value-based care model.
Led by CEO Chris Riopelle, Strive Health specializes in value-based kidney care partnering with innovative healthcare payors and providers. Using a combination of technology-enabled care interventions and integration with local providers, the company forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs.
As of May 2023, the company serves 80,000 CKD and ESKD patients across 30 states and partners with over 600 nephrology providers across 10 states. Strive currently manages over $2.5 billion of annual medical spend.